Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Sickle cell disease: old discoveries, new concepts, and future promise
Paul S. Frenette, George F. Atweh
Paul S. Frenette, George F. Atweh
Published April 2, 2007
Citation Information: J Clin Invest. 2007;117(4):850-858. https://doi.org/10.1172/JCI30920.
View: Text | PDF
Science in Medicine

Sickle cell disease: old discoveries, new concepts, and future promise

  • Text
  • PDF
Abstract

The discovery of the molecular basis of sickle cell disease was an important landmark in molecular medicine. The modern tools of molecular and cellular biology have refined our understanding of its pathophysiology and facilitated the development of new therapies. In this review, we discuss some of the important advances in this field and the impediments that limit the impact of these advances.

Authors

Paul S. Frenette, George F. Atweh

×

Figure 2

Chromosomal organization of the α- and β-globin gene clusters.

Options: View larger image (or click on image) Download as PowerPoint
Chromosomal organization of the α- and β-globin gene clusters.
(A) The g...
(A) The genes of the β-globin gene cluster (ε, Gγ, Aγ, δ, and β) are present on chromosome 11 in the same order in which they are expressed during development. The β–locus control region (β–LCR) is a major regulatory element located far upstream of the genes of the cluster that is necessary for the high level of expression of those genes. (B) The genes of the α-globin gene cluster (ζ, α1, and α2) are present on chromosome 16, also in the same order in which they are expressed during development. HS-40 is a major regulatory element located far upstream of the genes of the cluster that is necessary for their high level of expression. (C) During fetal life, Hb F (α2γ2) is the predominant type of hemoglobin. Hemoglobin switching refers to the developmental process that leads to the silencing of γ-globin gene expression and the reciprocal activation of adult β-globin gene expression. This results in the replacement of Hb F by Hb A (α2β2) as the predominant type of hemoglobin in adult life. Figure modified from ref. 128.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts